BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald

Generated: February 23, 2018

DrugPatentWatch Database Preview

Ingredient-type: Polyenes

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci IncABELCETamphotericin bINJECTABLE, LIPID COMPLEX;INJECTION050724-001Nov 20, 1995RXYesYes➤ Sign Up➤ Sign UpY➤ Sign Up
AstellasAMBISOMEamphotericin bINJECTABLE, LIPOSOMAL;INJECTION050740-001Aug 11, 1997RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
X Gen PharmsAMPHOTERICIN Bamphotericin bINJECTABLE;INJECTION063206-001Apr 29, 1992RXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
G And W Labs IncMYKACETnystatin; triamcinolone acetonideCREAM;TOPICAL062367-001May 28, 1985ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
G And W Labs IncMYKACETnystatin; triamcinolone acetonideOINTMENT;TOPICAL062733-001Mar 6, 1987ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Novartis Pharms CorpNATACYNnatamycinSUSPENSION;OPHTHALMIC050514-001Approved Prior to Jan 1, 1982RXYesYes➤ Sign Up➤ Sign Up➤ Sign Up
Actavis Mid AtlanticNYSTATINnystatinCREAM;TOPICAL062949-001Jun 13, 1988ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Mayne Pharma IncNYSTATINnystatinPOWDER;TOPICAL065203-001Jul 15, 2004ATRXNoYes➤ Sign Up➤ Sign Up➤ Sign Up
Gavis PharmsNYSTATINnystatinPOWDER;TOPICAL065138-001Jul 23, 2004ATRXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
Taro PharmNYSTATINnystatinSUSPENSION;ORAL062876-001Feb 29, 1988AARXNoNo➤ Sign Up➤ Sign Up➤ Sign Up
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Queensland Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: